Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine TAP Block for Post-Cesarean Opioid Reduction
NCT04680221Phase 4Active, not recruiting
- Sponsor
- University of Missouri-Kansas City
- Start
- Mar 2021
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in postoperative pain, sponsored by University of Missouri-Kansas City. Started Mar 2021; status: active, not recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04680221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04680221.